Netherlands, Sept. 23 -- Netherlands based Merck Sharp & Dohme B.V. has secured contract from NACIONALNI INSTITUT ZA JAVNO ZDRAVJE for General anti-infectives for systemic use and vaccines - PURCHASE OF CAPTIVA PCV 21 AND KAPIVA PROTEIN RSV . The value of the contract is worth 416600 EUR .
Published by HT Digital Content Services with permission from Pivotal Sources....